FDA studies possible pre-cancerous link with diabetes drugs!
The Food and Drug Administration is studying unconfirmed reports that a widely used class of diabetes drugs, which includes Merck & Co's Januvia, may cause inflammation of the pancreas and pre-cancerous changes to the pancreas. The agency, in a notice on its website on Thursday, said this is the first time it has communicated potential pre-cancerous links to the medicines, known as incretin mimetics. The drugs for type 2 diabetes also include Victoza from Danish drugmaker Novo Nordisk and Onglyza from Bristol-Myers Squibb Co and … Read More...
April 25, 2012 ~ Dr. Melvin R. Stjernholm On Diabetes Management.
Melvin R. Stjernholm, M.D., FACP, FACP
Dr. Stjernholm is Clinical Professor of Medicine University of Colorado Health Sciences Center in Denver. He completed his fellowship in endocrinology at the University of Colorado and subsequently started private practice at Boulder Community Hospital in Boulder Colorado. His practice has been limited to diabetes, thyroid disorders and osteoporosis.
He has done clinical research in the area of diabetes and published papers in multiple journals. He is co-author of “What to Do When the Doctor Says It’s Diabetes” .
Dr. Stjernholm is co-chair of the Clinical Diabetes Endocrine Institute held annually for the education of physicians and allied health professionals.
He is a member of the American Diabetes Association, the American Association of Clinical Endocrinologists and the Endocrine Society.
He is past president of the Boulder County Medical Society and board member of the Colorado Medical Society.
He has a major interest in international microenterprise development to help the poor improve their financial status.
Listen to Diabetes Living Today® interview:
April 25, 2012 ~ Dr. Melvin R. Stjernholm On Diabetes Management.
April 25, 2012 ~ Dr. Melvin R. Stjernholm On Diabetes Management. FDA Approves Lucentis® (Ranibizumab Injection) for Treatment of Diabetic Macular Edema (DME)
-- First Major Treatment Advance in More Than 25 Years for Sight-Threatening Condition -- South San Francisco, Calif. -- August 10, 2012 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that Lucentis® (ranibizumab injection) was approved by the U.S. Food & Drug Administration (FDA) for treatment of diabetic macular edema (DME), an eye condition in people with diabetes that causes blurred vision, severe vision loss and sometimes blindness. Diabetes is now the leading cause of … Read More...
See All Featured News
Diabetes Living Today® Host The Diabetes Research Institute Minute with Luca Inverardi, M.D.
Luca Inverardi, M.D., is Research Professor of Medicine, Microbiology and Immunology at the University of Miami Miller School of Medicine. In addition, he serves as Director of Immunobiology of Islet Transplantation and Area Leader of Cell Products and Stem Cell Research at the Diabetes Research Institute. Much of Dr. Inverardi’s research interests lie in developing ways to make biological replacement of insulin-producing tissue reproducibly successful in a large cohort of patients. This area of investigation focuses on a broad range of … Read More...
See All DRI Minute
Recently On The Radio
April 25, 2012 ~ Dr. Melvin R. Stjernholm On Diabetes Management.
Melvin R. Stjernholm, M.D., FACP, FACP Dr. Stjernholm is Clinical Professor of Medicine University of Colorado Health Sciences Center in Denver. He completed his fellowship in endocrinology at the University of Colorado and subsequently started private practice at Boulder Community Hospital in Boulder Colorado. His practice has been limited to diabetes, thyroid disorders and osteoporosis. He has done clinical research in the area of diabetes and published papers in multiple journals. He is co-author of "What to Do When the Doctor Says … [Read More...]
Diabetes Living Today® Highlights
April 10, 2012 ~ Diabetes Self Management with Stephanie Smith,Registered Dietitian and Certified Diabetes Educator.
Stephanie Smith, RD, CDE Stephanie Smith, RD, CDE: Registered Dietitian and Certified Diabetes Educator … [Read More...]
March 21, 2012 ~ Endocrinologist Dr. Richard O. Dolinar on Diabetes Management
Dr. Richard O. Dolinar A private practice Clinical Endocrinologist in Phoenix, Arizona, … [Read More...]
February 29, 2012 ~ Dr. Marc L. Schwartz, Cardiologist
Dr. Schwartz is a board certified cardiologist and clinical associate professor of medicine at Thomas … [Read More...]
No Sugar Added®
“Merry Christmas” There is a Santa Claus and a God!
My Christmas Gift Came, I Am Out Of Rejection! As many of you may know I have been battling rejection … [Read More...]
Few With Diabetes Risk See Need for Lifestyle Counseling
Many patients who are at risk for developing type 2 diabetes do not perceive the need for lifestyle … [Read More...]
Medtronic remote diabetes monitor gets US approval
CHICAGO - Medtronic Inc on Wednesday said it received U.S. regulatory approval for the first remote … [Read More...]
Kitty Castellini Wins Roche Diabetes Care’s Diabetes Heroes’ Torchbearer Challenge Roche to make $10,000 donation in Castellini’s name to South Jersey JDRF Chapter
Indianapolis, Dec. 2, 2011 INDIANAPOLIS—Roche Diabetes Care, makers of ACCU-CHEK products and services, … [Read More...]
